Skip to main content

Advertisement

SpringerLink
Log in

Radiochemotherapy and brachytherapy could be the standard treatment for anal canal cancer in elderly patients? A retrospective single-centre analysis

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Goal To retrospectively analyse all our elderly patients (>70 years old) treated with radiotherapy ± chemotherapy (RT ± CT) followed by brachytherapy (BRT) for anal canal cancer. Background Studies on clinical outcomes and toxicities of the standard treatments for anal canal cancers in elderly patients are rare and data are not homogeneous, so a standard of care cannot be defined for these patients. Study A retrospective analysis of efficacy and safety of RT ± CT followed by BRT has been performed. The impact of the modified Charlson Index and of other different clinical and therapeutic variables on these outcomes has been also studied. Results Seventy-six elderly patients with a histological diagnosis of anal canal cancer and with a median age of 76 years (range 70–88) were treated with a curative goal. Patients received radiotherapy alone (37/76, “RT group”) or radiochemotherapy (39/76, “RT–CT group”). All patients underwent a BRT boost. Five-year local control, overall survival, disease-specific survival, nodal progression-free survival and metastasis-free survival rates were 75.8, 75.8, 82.8. 87.8 and 89.0 %, respectively. Globally, the incidence of acute and late Grade 3–4 toxicities was 14.5 and 6.6 %, respectively. Only 2 patients received surgery because of severe ano-rectal toxicities. Any relationship between the modified Charlson Index and all the considered clinical outcomes was found. Conclusions Curative RT ± CT + BRT showed an acceptable toxicity profile and a good efficacy also in elderly anal canal cancer patients and should be considered as an important therapeutic option also for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Halperin EC, Perez CA, Brady LW. Perez and Brady’s principles and practice of radiation oncology. 5th ed. Chapter 59—Anal Cancer. 2008. p. 1386.

  2. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer. 1997;80:1273–83.

    Article  PubMed  CAS  Google Scholar 

  3. Yancik R, Ries LA. Cancer in older persons: an international issue in an aging world. Semin Oncol. 2004;31:128–36.

    Article  PubMed  Google Scholar 

  4. Monfardini S, Falci C, Brunello A, et al. Cancer in the elderly. Intern Emerg Med. 2011;6(Suppl 1):115–8.

    Article  PubMed  Google Scholar 

  5. Niyazi M, Schwarz SB, Suchorska B, et al. Radiotherapy with and without temozolomide in elderly patients with glioblastoma. Strahlenther Onkol. 2012;188(2):154–9.

    Article  PubMed  CAS  Google Scholar 

  6. Firat S, Bousamra M, Gore E, et al. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002;52:1047–57.

    Article  PubMed  Google Scholar 

  7. Rochon PA, Katz JN, Morrow LA, et al. Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. Med Care. 1996;34:1093–101.

    Article  PubMed  CAS  Google Scholar 

  8. Satariano WA, Ragland DA. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994;120:104–10.

    PubMed  CAS  Google Scholar 

  9. Extermann M, Aapro M, Bernabei R, et al. Task force on CGA of the International Society of Geriatric Oncology. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55:241–52.

    Article  PubMed  Google Scholar 

  10. Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol. 2000;35(3):181–200.

    Article  PubMed  CAS  Google Scholar 

  11. Allal AS, Obradovic M, Laurencet F, et al. Treatment of anal carcinoma in the elderly feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy. Cancer. 1999;85(1):26–31.

    Article  PubMed  CAS  Google Scholar 

  12. Charnley N, Choudhury A, Chesser P, et al. Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy. Br J Cancer. 2005;92:1221–5.

    Article  PubMed  CAS  Google Scholar 

  13. De Bari B, Lestrade L, Chekrine T, et al. Should the treatment of anal carcinoma be adapted in the elderly? A retrospective analysis of acute toxicities in a French centre and a review of the literature. Cancer Radiother. 2012;16(1):52–7. Article in French.

    Article  PubMed  Google Scholar 

  14. Fallai C, Cerrotta A, Valvo F, et al. Anal carcinoma of the elderly treated with radiotherapy alone or with concomitant radio-chemotherapy. Crit Rev Oncol Hematol. 2007;61:261–8.

    Article  PubMed  Google Scholar 

  15. Saarilahti K, Arponen P, Vaalavirta L, et al. Chemoradiotherapy of anal cancer is feasible in elderly patients: treatment results of mitomycin-5-FU combined with radiotherapy at Helsinki University Central Hospital 1992–2003. Acta Oncol. 2006;45(6):736–42.

    Article  PubMed  Google Scholar 

  16. Valentini V, Morganti AG, Luzi S, et al. Is chemoradiation feasible in elderly patients? Cancer. 1997;80:1387–92.

    Article  PubMed  CAS  Google Scholar 

  17. National Cancer Institute. Common terminology criteria for adverse events (CTCAE), version 4.0. 2009 May. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf.

  18. Womack NR, Morrison JF, Williams NS. Prospective study of the effects of postanal repair in neurogenic faecal incontinence. Br J Surg. 1988;75:48–52.

    Article  PubMed  CAS  Google Scholar 

  19. Zekrya D, Loures Valle BH, Lardia C, et al. Geriatrics index of comorbidity was the most accurate predictor of death in geriatric hospital among six comorbidity scores. J Clin Epidemiol. 2010;63(9):1036–44.

    Article  Google Scholar 

  20. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51.

    Article  PubMed  CAS  Google Scholar 

  21. Chapet O, Gerard JP, Riche B, Alessio A, Mornex F, Romestaing P. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys. 2005;63(5):1316–24.

    Article  PubMed  Google Scholar 

  22. Giordano FA, Wenz F. Negative influence of undertreatment in elderly patients with breast cancer. Strahlenther Onkol. 2012;188(6):527–8. German.

    Article  PubMed  CAS  Google Scholar 

  23. Djunic I, Virijevic M, Novkovic A, Djurasinovic V, Colovic N, Vidovic A, Suvajdzic-Vukovic N, Tomin D. Comorbidity as a risk factor for overall survival and decision criteria for intensity of chemotherapy in elderly patients with acute myeloid leukemia. Med Oncol. 2012;29(2):1077–81. [Epub 2011 Feb 18].

    Article  PubMed  Google Scholar 

  24. Irvin TT. Prognosis of colorectal cancer in the elderly. Br J Surg. 1988;75:419–21.

    Article  PubMed  CAS  Google Scholar 

  25. Karl RC, Smith SK, Fabri PJ. Validity of major cancer operations in elderly patients. Ann Surg Oncol. 1995;2(107–13):19–21.

    Google Scholar 

  26. Balducci M, Fiorentino A, De Bonis P, et al. Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies. Med Oncol. 2012;29(5):3478–83.

    Article  PubMed  Google Scholar 

  27. Papillon J, Montbarbon JF. Epidermoid carcinoma of the anal canal. A series of 279 cases. Dis Colon Rectum. 1987;30(5):324–33.

    Article  PubMed  CAS  Google Scholar 

  28. Sandhu AP, Symonds RP, Robertson AG, et al. Interstitial iridium-192 implantation combined with external radiotherapy in anal cancer: ten years experience. Int J Radiat Oncol Biol Phys. 1998;40(3):575–81.

    Article  PubMed  CAS  Google Scholar 

  29. Crowley C, Winship AZ, Hawkins MA, et al. Size does matter: can we reduce the radiotherapy field size for selected cases of anal canal cancer undergoing chemoradiation? Clin Oncol (R Coll Radiol). 2009;21(5):376–9.

    Article  CAS  Google Scholar 

  30. Guckenberger M, Ok S, Polat B, et al. Toxicity after intensity modulated, image-guided radiotherapy for prostate cancer. Strahlenther Onkol. 2010;186(10):535–43.

    Article  PubMed  Google Scholar 

  31. Sanguineti G, Endres EJ, Sormani MP, et al. Dosimetric predictors of diarrhea during radiotherapy for prostate cancer. Strahlenther Onkol. 2009;185(6):390–6.

    Article  PubMed  Google Scholar 

  32. Treutwein M, Hipp M, Kölbl O, et al. IMRT of prostate cancer: a comparison of fluence optimization with sequential segmentation and direct step-and-shoot optimization. Strahlenther Onkol. 2009;185(6):379–83.

    Article  PubMed  Google Scholar 

  33. Fiorino C, Valdagni R, Rancati T, et al. Dose–volume effects for normal tissues in external radiotherapy: pelvis. Radiother Oncol. 2009;93(2):153–67.

    Article  PubMed  Google Scholar 

  34. Milano MT, Jani AB, Farrey KJ, et al. Intensity modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys. 2005;63:354–61.

    Article  PubMed  Google Scholar 

  35. Saarilahti K, Arponen P, Vaalavirta L, et al. The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer. Radiother Oncol. 2008;87(3):383–90.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Service de Radiothérapie Oncologie, Centre de Lutte Contre le Cancer Léon Bérard, Lyon, France

    Laetitia Lestrade, Xavier Montbarbon, Pascal Pommier & Christian Carrie

  2. Radiation Oncology Department, Spedali Civili di Brescia, Istituto del Radio “O. Alberti”, University of Brescia, Brescia, Italy

    Berardino De Bari

  3. AO Spedali Civili-Istituto del Radio “O. Alberti”, Università degli Studi di Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy

    Berardino De Bari

Authors
  1. Laetitia Lestrade
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Berardino De Bari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xavier Montbarbon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pascal Pommier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christian Carrie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Berardino De Bari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lestrade, L., De Bari, B., Montbarbon, X. et al. Radiochemotherapy and brachytherapy could be the standard treatment for anal canal cancer in elderly patients? A retrospective single-centre analysis. Med Oncol 30, 402 (2013). https://doi.org/10.1007/s12032-012-0402-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-012-0402-x

Keywords

Search

Navigation